numbers crunched for you before earnings results Cardiff Oncology Inc (NASDAQ:CRDF)

0
46

Earnings results for Cardiff Oncology Inc (NASDAQ:CRDF)

Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingMar 2020 , the consensus EPS* forecast has remained the same over the past week at 999 and remained the same over the past month at 999. none raised and none lowered their forecast. For the fiscal year ending Dec 2020 , the consensus EPS* forecast has remained the same over the past week at 999 and remained the same over the past month at 999 . none raised and none lowered their forecast.

Creative Realities last posted its quarterly earnings data on May 7th, 2020. The reported ($0.41) earnings per share for the quarter. The company earned $0.07 million during the quarter. Creative Realities has generated ($2.80) earnings per share over the last year. Creative Realities has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, June 30th, 2020 based off prior year’s report dates.

Analyst Opinion on Cardiff Oncology Inc (NASDAQ:CRDF)

2 Wall Street analysts have issued ratings and price targets for Creative Realities in the last 12 months. Their average twelve-month price target is $14.50, suggesting that the stock has a possible upside of 186.00%. The high price target for CRDF is $23.00 and the low price target for CRDF is $6.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Creative Realities has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $14.50, Creative Realities has a potential upside of 186.0% from its current price of $5.07. Creative Realities has only been the subject of 2 research reports in the past 90 days.

Dividend Strength: Cardiff Oncology Inc (NASDAQ:CRDF)

Creative Realities does not currently pay a dividend. Creative Realities does not have a long track record of dividend growth.

Insiders buying/selling: Cardiff Oncology Inc (NASDAQ:CRDF)

In the past three months, Creative Realities insiders have not sold or bought any company stock. Only 0.60% of the stock of Creative Realities is held by insiders. Only 4.59% of the stock of Creative Realities is held by institutions.

Earnings and Valuation of Cardiff Oncology Inc (NASDAQ:CRDF

The P/E ratio of Creative Realities is -1.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Creative Realities is -1.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Creative Realities has a P/B Ratio of 5.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here